12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

AlphaVax, Harrisvaccines deal

AlphaVax expanded an exclusive license with Harrisvaccines to include rights to use AlphaVax's RNA particle technology...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >